Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

J&J joins 'menin party' at ASH; GSK to work with Oxford BioTherapeutics

Summary by endpoints.news
Plus, news about Sanofi, InduPro Therapeutics, Denali and Biocytogen: 📊 Johnson & Johnson's menin inhibitor data at #ASH25: Kura and Syndax weren’t the only companies to present menin ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

endpoints.newsendpoints.news

J&J joins 'menin party' at ASH; GSK to work with Oxford BioTherapeutics

Plus, news about Sanofi, InduPro Therapeutics, Denali and Biocytogen: 📊 Johnson & Johnson's menin inhibitor data at #ASH25: Kura and Syndax weren’t the only companies to present menin ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Wednesday, December 10, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Johnson & Johnson icon

Johnson & Johnson

Denali icon

Denali

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal